Leadership: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 29: | Line 29: | ||
File:Kitahara, Sumire 2023.jpg|Sumire K. Kitahara, MD, Associate Professor, Pathology & Laboratory Medicine, Cedars-Sinai (Los Angeles); '''[mailto:Sumire.Kitahara@cshs.org <u>Sumire.Kitahara@cshs.org</u>]'''; '''Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]''' | File:Kitahara, Sumire 2023.jpg|Sumire K. Kitahara, MD, Associate Professor, Pathology & Laboratory Medicine, Cedars-Sinai (Los Angeles); '''[mailto:Sumire.Kitahara@cshs.org <u>Sumire.Kitahara@cshs.org</u>]'''; '''Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]''' | ||
File:Professional headshot.jpg|Kathleen Schieffer, PhD, FACMG, Clinical Laboratory Director, Institute for Genomic Medicine, Nationwide Children’s Hospital; Assistant Professor, Departments of Pathology and Pediatrics, The Ohio State University; '''[mailto:Kathleen.Schieffer@nationwidechildrens.org <u>Kathleen.Schieffer@nationwidechildrens.org</u>]'''; '''Associate Editor CCGA [Soft Tissue and Bone Tumours]''' | |||
</gallery> | </gallery> | ||